Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Clin Nutr ESPEN. 2022 Oct 26;52:158–168. doi: 10.1016/j.clnesp.2022.10.007

Figure 4:

Figure 4:

Time-dependent changes in the model-adjusted means of breast tissue components measured by MRI in premenopausal women treated with isoflavones (n=97) or placebo (n=97) after mean treatment periods of 1.2 and 2.2 years. These estimates using model 4 (Table 3) were for square root transformed outcomes. FGBT, fibroglandular breast tissue in cc, FGBT%, FGBT as percent of total breast, and FBT, fatty breast tissue in cc.